Entrée Capital
Israeli early-stage venture firm.
Investing activity
Entrée Capital appears in 3 AI deals tracked by the AI Lounge deals desk, rounds totalling $44M, and led 2 of them. The rounds are mostly Seed and Series A, with a median round size of $18M and the largest at $26M. The most recent are Undecimal Bio (Seed, $18M, Oct 2026), Chamelio (Series A, $26M, Sep 2026) and Catch (Seed, $5M, Sep 2026).
Entrée Capital most often invests alongside 4BIO Capital, IQ Capital, Kerna Ventures and Verve Ventures, and the companies it backs on AI Lounge are mostly in AI and Legal AI agents.
Deals
Frequently asked questions about Entrée Capital
What AI companies has Entrée Capital invested in?
Entrée Capital's AI investments include Undecimal Bio, Chamelio and Catch. The 3 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Entrée Capital based?
Entrée Capital is based in Tel Aviv, Israel.
What stage does Entrée Capital invest at?
In the rounds tracked on AI Lounge, Entrée Capital has invested at Seed and Series A, with a median round of $18M. Entrée Capital led 2 of those rounds.
Who does Entrée Capital co-invest with?
Entrée Capital's most frequent co-investors on AI Lounge are 4BIO Capital (1 deal), IQ Capital (1 deal), Kerna Ventures (1 deal), Verve Ventures (1 deal) and Harel Insurance and Financial (1 deal).
How can founders reach Entrée Capital?
Founders on AI Lounge can see Entrée Capital's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Entrée Capital to their Investor Pipeline to track the conversation.